[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-343581-105":59,"doc-detail-343581-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","amplification-of-myc-and-its-enhancer-correlates-with-genetic-ancestry-in-lung-squamous-cell-carcinoma-original-reports","Ampliﬁcation of MYC and Its Enhancer Correlates With Genetic Ancestry in Lung Squamous Cell Carcinoma - Original Reports","","Lung squamous cell carcinoma (LUSC) shows a survival disadvantage for Black patients compared with White patients, yet genomic mechanisms underlying this disparity remain unclear. Using 416 LUSC tumor samples from TCGA and replicating in pan-cancer cohorts, amplification patterns were assessed by genetic ancestry. MYC amplification, LUSC-specific MYC enhancer amplification, and chr8q gain correlated with African ancestry, with enrichment of MYC target gene expression. Findings suggest ancestry-linked drivers and potential for future anti-MYC strategies.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/amplification-of-myc-and-its-enhancer-correlates-with-genetic-ancestry-in-lung-squamous-cell-carcinoma-original-reports/343581/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/amplification-of-myc-and-its-enhancer-correlates-with-genetic-ancestry-in-lung-squamous-cell-carcinoma-original-reports/343581.png","ImageObject",300,407,{"name":92,"@type":93},"Sage","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What question does the study address in lung squamous cell carcinoma (LUSC)?","Question",{"text":113,"@type":114},"The study investigates whether genomic alterations associated with ancestry can explain disparities in lung cancer outcomes, focusing on patterns that correlate with African ancestry in LUSC and across cancers.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which genomic events were found to correlate with African ancestry in LUSC?",{"text":118,"@type":114},"In TCGA LUSC samples, increased MYC amplification, LUSC-specific MYC enhancer amplification, and chromosome arm 8q (chr8q) gain were significantly associated with African (AFR) ancestry.",{"name":120,"@type":111,"acceptedAnswer":121},"How were the findings validated and what is the implication for therapy research?",{"text":122,"@type":114},"Analyses were replicated in pan-cancer datasets including TCGA and AACR GENIE and a clinical cohort. The results support ancestry-linked oncogenic mechanisms and emphasize including African-ancestry patients in translational and clinical studies for future anti-MYC approaches.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},343581,1790198696,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687197207057,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Original Reports | Cancer Genomics  \nAmpliﬁcation of MYC and Its Enhancer Correlates With Genetic Ancestry in Lung Squamous Cell Carcinoma  \nSejal Jain, MD1,2 ; Xuechun Bai, BS3 ; Samyukta Mallick, MA, MPhil4,5,6 ; Branden Kinghorn, BS7,8; Benjamin May, BS6; Alexandria G. Yao, BA9 ; Diane Allen-Gipson, PhD, MS10 ; Xiaoyang Zhang, PhD7,8; Brian S. Henick, MD6,11  ; Fatemeh Momen-Heravi, PhD, MPH, DDS6,12 ; Jian Carrot-Zhang, PhD3,13; and Alison M. Taylor, PhD4,6   \nDOI [https://doi.org/10.1200/PO.24.00223](https://doi.org/10.1200/PO.24.00223)  \n\n| ABSTRACT |  |\n| --- | --- |\n| PURPOSE | In lung squamous cell carcinoma (LUSC), Black patients show signiﬁcantly higher incidence and lower overall survival than White patients. Although socioeconomic factors likely contribute to this survival disparity, genomic factors have yet to be elucidated in LUSC. |\n| METHODS | Using 416 LUSC tumor samples in the Cancer Genome Atlas (TCGA), we assessed genomic and transcriptomic proﬁles by ancestry. We replicated our analyses in pan-cancer data from TCGA, the American Association of Cancer Research (AACR) Genomics Evidence Neoplasia Information Exchange (GENIE), and Columbia University Medical Center. |\n| RESULTS | We found increased MYC ampliﬁcation, LUSC-speciﬁc MYC enhancer ampliﬁcation, and chromosome arm 8q (chr8q) gain to be signiﬁcantly associated with genetic AFR (African) ancestry in LUSC in TCGA. Furthermore, expression of MYC target genes was signiﬁcantly enriched in AFR samples. Local ancestry analysis identiﬁed correlation of chr8q gain with AFR ancestry at the MYC locus in TCGA. We also found a signiﬁcant correlation between chr8q and AFR ancestry in multiple cancer types and pan-cancer in TCGA. Similarly, ina pan-cancer subset of AACR GENIE data, we found a signiﬁcant correlation between chr8q gain and race. |\n| CONCLUSION | Together, our data suggest that ancestry may inﬂuence ampliﬁcation of not only MYC but also its enhancer in LUSC. They also suggest a role for genetic ancestry in chr8q aneuploidy in cancer. These studies further deﬁne and expand patients who may beneﬁt from future anti-MYC therapeutic approaches. |\n\nACCOMPANYING CONTENT  \n Data Supplement  \nAccepted August 28, 2024 Published October 24, 2024  \nJCO Precis Oncol 8:e2400223 © 2024 by American Society of Clinical Oncology  \nCreative Commons Attribution Non-Commercial No Derivatives 4.0 License  \nINTRODUCTION  \nThe morbidity and mortality of lung cancer disproportionately affect racial and ethnic minorities, particularly Black/African American patients.1-3 This disparity is thought to be largely attributable to socioeconomic and environmental factors.1-10 However, germline risk variants and differential somatic alterations have been identiﬁed in Black populations for colorectal, breast, and prostate cancers11-15; this has informed population-speciﬁc risk stratiﬁcation and screening paradigms.5,16-18 Cancer sequencing databases feature disproportionately low samples from Black patients and other racial/ethnic minorities.19  \nMany recent studies have leveraged genetic ancestry to overcome limitations of self-reported race-based analyses and elucidate ancestry-speciﬁc patterns in tumor biology.20,21 A comprehensive analysis of ancestry-related correlates in cancer found many tissue-speciﬁc effects and identiﬁed ancestry-speciﬁc mutation rates and genomic hallmarks.20  \nHere, in 416 lung squamous cell carcinoma (LUSC) tumors from the Cancer Genome Atlas (TCGA),22 we ﬁnd that copy number gains of MYC, a LUSC-speciﬁc enhancer on chr8q24.21, and chromosome arm 8q (chr8q) all correlate with African (AFR) ancestry. We replicate our ﬁndings in pan-cancer cohorts, including TCGA, AACR GENIE, and a clinical cohort at the Columbia University Irving Medical Center (CUIMC) . Our results suggest ancestry-speciﬁc patterns of oncogenic alterations that may modulate treatment response and survival in LUSC.  \nMETHODS  \nData Sets  \nTCGA  \nA total of 10,522 TCGA samples were assigned ","cbCaigztrv3fs5rz","https://ap.wps.com/l/cbCaigztrv3fs5rz","pdf",1447571,"English","# Abstract\n## Purpose\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Context and objective\n# Methods\n## Data sets\n# Context\n## Key objective\n## Knowledge generated\n## Relevance","[{\"question\":\"What question does the study address in lung squamous cell carcinoma (LUSC)?\",\"answer\":\"The study investigates whether genomic alterations associated with ancestry can explain disparities in lung cancer outcomes, focusing on patterns that correlate with African ancestry in LUSC and across cancers.\"},{\"question\":\"Which genomic events were found to correlate with African ancestry in LUSC?\",\"answer\":\"In TCGA LUSC samples, increased MYC amplification, LUSC-specific MYC enhancer amplification, and chromosome arm 8q (chr8q) gain were significantly associated with African (AFR) ancestry.\"},{\"question\":\"How were the findings validated and what is the implication for therapy research?\",\"answer\":\"Analyses were replicated in pan-cancer datasets including TCGA and AACR GENIE and a clinical cohort. The results support ancestry-linked oncogenic mechanisms and emphasize including African-ancestry patients in translational and clinical studies for future anti-MYC approaches.\"}]","Ampliﬁcation of MYC and Its Enhancer Correlates With Genetic Ancestry in Lung Squamous Cell Carcinoma - Original Reports | PDF",1790051473,25,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d3935d766e05297b8093f2a63db96d73.webp",983,1315,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bbbc01dab868b58e871ce50443117f14.webp",982,1314,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d86cabd3d50410c9660909b2001e53bb.webp",981,1312,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e071ed660ebe66cfc0456eeee1b29c11.webp",980,1311]